Subscribe to RSS
DOI: 10.1055/s-0028-1087369
On the Way to an Oxidative Hosomi-Sakurai Reaction
Publication History
Publication Date:
26 November 2008 (online)
Abstract
An oxidative allylation process mediated by a hypervalent iodine reagent has been performed on polysubstituted phenols. This reaction, occurring in useful to good yields, leads to a rapid access to dienones containing a quaternary carbon center.
Key words
hypervalent iodine - allyltrimethylsilane - substitued phenols - oxidative allylation
- 1
Hosomi A.Sakurai H. Tetrahedron Lett. 1976, 1295 -
2a
Tamura Y.Yakura T.Haruta J.Kita Y. J. Org. Chem. 1987, 52: 3927 -
2b
Kita Y.Tohma H.Hatanaka K.Takada T.Fujita S.Mitoh S.Sakurai H.Oka S. J. Am. Chem. Soc. 1994, 116: 3684 -
2c
Kita Y.Takada T.Gyoten M.Tohma H.Zenk MH.Eichhorn J. J. Org. Chem. 1996, 61: 5854 -
2d
Kita Y.Gyoten M.Ohtsubo M.Tohma H.Takada T. Chem. Commun. 1996, 1481 -
2e
Takada T.Arisawa M.Gyoten M.Hamada R.Tohma H.Kita Y. J. Org. Chem. 1998, 63: 7698 -
2f
Arisawa M.Utsumi S.Nakajima M.Ramesh NG.Tohma H.Kita Y. Chem. Commun. 1999, 469 -
2g
Akai S.Kawashita N.Morita N.Nakamura Y.Iio K.Kita Y. Heterocycles 2002, 58: 75 -
2h
Dohi T.Maruyama A.Takenaga N.Senami K.Minamitsuji Y.Fujioka H.Caemmerer SB.Kita Y. Angew. Chem. Int. Ed. 2008, 47: 3787 -
3a
Moreno I.Tellitu I.SanMartín R.Domínguez E. Synlett 2001, 1161 -
3b
Tohma H.Iwata M.Maegawa T.Kita Y. Tetrahedron Lett. 2002, 43: 9241 -
3c
Akai S.Kawashita N.Morita N.Nakamura Y.Iio K.Kita Y. Heterocycles 2002, 58: 75 -
3d
Tohma H.Iwata M.Maegawa T.Kiyono Y.Maruyama A.Kita Y. Org. Biomol. Chem. 2003, 1: 1647 -
3e
Dohi T.Morimoto K.Kiyono Y.Maruyama A.Tohma H.Kita Y. Chem. Commun. 2005, 2930 -
3f
Dohi T.Morimoto K.Maruyama A.Kita Y. Org. Lett. 2006, 8: 2007 -
4a
Pelter A.Drake RA. Tetrahedron Lett. 1988, 29: 4181 -
4b
Gates BD.Dalidowicz P.Tebben A.Wang S.Swenton JS. J. Org. Chem. 1992, 57: 2135 -
4c
Quideau S.Pouységu L.Looney MA. J. Org. Chem. 1998, 63: 9597 -
4d
Quideau S.Looney MA.Pouységu L. Org. Lett. 1999, 1: 1651 -
4e
Quideau S. In Modern Arene ChemistryAstruc D. Wiley-VCH; Weinheim: 2002. p.539 -
4f
Quideau S.Pouységu L.Deffieux D. Curr. Org. Chem. 2004, 8: 113 -
4g
Ciufolini MA.Canesi S.Ousmer M.Braun NA. Tetrahedron 2006, 62: 5318 -
4h
Nicolaou KC.Edmonds DJ.Li A.Tria GS. Angew. Chem. 2007, 119: 4016 -
4i
Ciufolini MA.Braun NA.Canesi S.Ousmer M.Chang J.Chai D. Synthesis 2007, 3759 -
4j
Bérard D.Jean A.Canesi S. Tetrahedron Lett. 2007, 48: 8238 -
4k
Bérard D.Giroux MA.Racicot L.Sabot C.Canesi S. Tetrahedron 2008, 7537 -
4l
Quideau S.Pouységu L.Deffieux D. Synlett 2008, 467 -
4m
Pouységu L.Chassaing S.Dejugnac D.Lamidey AM.Miqueu K.Sotiropoulos JM.Quideau S. Angew. Chem. Int. Ed. 2008, 47: 3552 -
4n
Liang H.Ciufolini MA. J. Org. Chem. 2008, 4299 - 5
Jean A.Cantat J.Bérard D.Bouchu D.Canesi S. Org. Lett. 2007, 9: 2553 -
6a
Kita Y.Tohma H.Kikuchi K.Inagaki M.Yakura T. J. Org. Chem. 1991, 56: 435 -
6b
Hamamoto H.Anilkumar G.Tohma H.Kita Y. Chem. Eur. J. 2002, 8: 5377 - 7
Nicolaou KC.Edmonds DJ.Li A.Tria GS. Angew. Chem. 2007, 119: 4016 -
8a
Quideau S.Looney MA.Pouységu L. Org. Lett. 1999, 1: 1651 -
8b
Quideau S.Pouységu L.Oxoby M.Looney MA. Tetrahedron 2001, 57: 319 -
9a
Canesi S.Bouchu D.Ciufolini MA. Angew. Chem. Int. Ed. 2004, 43: 4336 -
9b
Imbos R.Minnaard AJ.Feringa BL. J. Am. Chem. Soc. 2002, 124: 184 -
9c
Hayashi Y.Gotoh H.Tamura T.Yamaguchi H.Masui R.Shoji M. J. Am. Chem. Soc. 2005, 127: 16028 -
9d
Liu Q.Rovis T. J. Am. Chem. Soc. 2006, 128: 2552 -
9e
Vo NT.Pace RDM.O’Hara F.Gaunt MJ. J. Am. Chem. Soc. 2008, 130: 404 -
10a
Kobayashi S.Shingu T.Uyeo S. Chem. Ind. 1956, 177 -
10b
Fan C.Tu Y.Song ZL.Zhang E.Shi L.Wang M.Wang B.Zhang SY. Org. Lett. 2004, 6: 4691 - 11
Nicolaou KC.Scott Tria G.Edmonds DJ. Angew. Chem. Int. Ed. 2008, 47: 1780 - 12
Bérard D.Racicot L.Sabot C.Canesi S. Synlett 2008, 1076 - 13
Ozanne-Beaudenon A.Quideau S. Angew. Chem. Int. Ed. 2005, 44: 7065 - 15
Clemo GR.Haworth RD.Walton E. J. Chem. Soc. 1930, 1110 - 16
Thadani AN.Huang Y.Rawal VH. Org. Lett. 2007, 9: 3873 - 19
Fleming I.Roessler F. J. Chem. Soc., Chem. Commun. 1980, 276
References and Notes
Analytical Data
IR:
ca. 1645 (CO) cm-¹.
Compound 13b: ¹H NMR (300 MHz,
CDCl3): δ = 6.33 (s,
2 H),
5.43 (m, 1 H), 4.92 (m, 2 H), 2.23 (d, 2 H, J = 7.8
Hz), 1.53 (m, 2 H), 1.19 (m, 22 H), 0.99 (m, 2 H), 0.80 (t, 3 H,
J = 6.6 Hz). ¹³C
NMR (150 MHz, CDCl3): δ = 187.3, 148.2, 145.7,
133.5, 118.1, 45.3, 44.1, 40.1, 35.1, 32.4, 29.9, 24.3, 22.7, 14.2.
ESI-HRMS: m/z calcd for C22H36ONa [M + Na]+: 339.2658;
found: 339.2662.
Compound 13c: ¹H
NMR (300 MHz, CDCl3): δ = 6.39 (s,
2
H), 5.43 (m, 1 H), 4.93 (m, 2 H), 2.32 (d, 2 H, J = 7.5
Hz), 1.83 (h, 1 H, J = 6.6 Hz),
1.21 (s, 18 H), 0.84 (d, 6 H, J = 6.6 Hz). ¹³C
NMR (150 MHz, CDCl3): δ = 187.4, 148.8,
144.3, 133.8, 117.8, 46.4, 42.4, 36.3, 35.3, 29.9, 18.2. ESI-HRMS: m/z calcd for C20H33O [M + H]+:
289.2525; found: 289.2529.
Compound 13d: ¹H
NMR (300 MHz, CDCl3): δ = 6.44 (s, 2 H),
5.48 (m, 1 H), 4.97 (m, 2 H), 3.42 (t, 2 H, J = 7.2
Hz), 2.30 (d, 2 H, J = 7.8 Hz),
1.92 (t, 2 H, J = 7.2 Hz), 1.27
(s, 18 H). ¹³C NMR (150 MHz, CDCl3): δ = 186.9,
148.4, 145.0, 132.7, 118.8, 60.0, 45.4, 42.9, 42.8, 35.2, 29.8 ESI-HRMS: m/z calcd for C19H30O2Na [M + Na]+:
313.2138; found: 313.2138.
Compound 13e: ¹H
NMR (300 MHz, CDCl3): δ = 6.50 (s,
2
H), 5.49 (m, 1 H), 4.97 (m, 2 H), 3.48 (s, 2 H), 2.35 (d,
2
H, J = 7.2 Hz), 1.22 (s, 18
H), 0.88 (s, 9 H), 0.03 (s, 6 H).
¹³C
NMR (150 MHz, CDCl3): δ = 187.2, 148.8,
143.0, 133.4, 118.3, 69.1, 45.7, 40.5, 35.2, 29.9, 26.1, 18.5, -5,1.
ESI-HRMS: m/z calcd for C24H43O2Si [M + H]+:
391.3026; found: 391.3008.
Compound 13f: ¹H
NMR (300 MHz, CDCl3): δ = 7.56 (d,
2
H, J = 7.5 Hz), 7.20 (d, 2 H, J = 7.5 Hz), 6.25 (s, 2 H),
5.35 (m, 1 H), 4.87 (m, 2 H), 4.29 (m, 1 H), 2.55 (q, 2 H, J = 6.6 Hz), 2.32 (s, 3 H),
2.17 (d, 2 H, J = 7.5 Hz), 1.79
(t, 2 H, J = 6.6 Hz), 1.10 (s,
18 H). ¹³C NMR (150 MHz, CDCl3): δ = 186.5,
149.1, 144.2, 144.0, 136.6, 132.3, 130.1, 127.3, 119.0, 45.3, 43.1,
40.1, 39.7, 35.2, 29.8, 21.8. ESI-HRMS: m/z calcd
for C26H37NO3SNa [M + Na]+:
466.2386; found: 466.2378.
Compound 13g: ¹H
NMR (300 MHz, CDCl3): δ = 6.49 (s,
2
H), 5.50 (m, 1 H), 4.01 (m, 2 H), 3.54 (s, 3 H), 2.54 (s, 2 H),
2.35 (d, 2 H, J = 7.2 Hz), 1.21
(s, 18 H). ¹³C NMR (150 MHz, CDCl3): δ = 186.7,
170.7, 148.1, 143.4, 132.5, 119.3, 51.7, 44.6, 44.3, 42.0, 35.2,
29.8. ESI-HRMS: m/z calcd for C20H31O3 [M + H]+:
319.2267; found: 319.2267.
Analytical Data
Compound 17a: ¹H
NMR (300 MHz, CDCl3): δ = 6.86 (s,
2
H), 5.52 (m, 1 H), 4.99 (m, 2 H), 2.26 (d, 2 H, J = 7.2
Hz), 1.20 (s, 3 H), 0.16 (s, 18 H). ¹³C
NMR (150 MHz, CDCl3):
δ = 192.0,
162.4, 140.7, 133.3, 118.6, 45.2, 41.4, 25.5, -0.9. ESI-HRMS: m/z calcd for C16H29OSi2 [M + H]+:
293.1751; found: 293.1753.
Compound 17b: ¹H
NMR (300 MHz, CDCl3): δ = 6.77 (s,
2
H), 5.51 (m, 1 H), 4.99 (dd, 1 H, J = 8.7,
1.2 Hz), 4.96 (dd, 1 H, J = 18.0,
1.2 Hz), 2.29 (d, 2 H, J = 7.2
Hz), 1.63 (q,
2 H, J = 7.8
Hz), 0.68 (t, 3 H, J = 7.8 Hz),
0.16 (s, 18 H).
¹³C NMR (150
MHz, CDCl3): δ = 192.4, 161.3, 143.0,
133.3, 118.3, 46.1, 44.3, 32.1, 9.3, -0.8. ESI-HRMS: m/z calcd for C17H31OSi2 [M + H]+:
307.1908; found: 307.1909.
Compound 17c: ¹H
NMR (300 MHz, CDCl3): δ = 7.30 (m,
5
H), 7.00 (s, 2 H), 5.56 (m, 1 H), 5.05 (m, 2 H), 2.80 (d,
2
H, J = 7.2 Hz), 0.18 (18 H). ¹³C
NMR (150 MHz, CDCl3): δ = 192.1, 160.7,
141.1, 140.8, 132.9, 129.3, 127.6, 127.0, 119.0, 48.6, 42.3, -0.9.
ESI-HRMS: m/z calcd for C21H31OSi2 [M + H]+:
355.1908; found: 355.1914.
Compound 17d: ¹H
NMR (300 MHz, CDCl3): δ = 6.86 (s,
2
H), 5.47 (m, 1 H), 4.98 (m, 2 H), 3.42 (t, 2 H, J = 6.9
Hz), 2.29 (d, 2 H, J = 7.2 Hz),
1.92 (t, 2 H, J = 6.9 Hz), 0.14
(s, 18 H). ¹³C NMR (150 MHz, CDCl3): δ = 192.1,
160.9, 142.7, 132.5, 119.1, 60.0, 44.7, 44.4, 42.0, -0.9.
ESI-HRMS: m/z calcd for C17H31O2Si2 [M + H]+:
323.1857; found: 323.1853.
Analytical Data
Compound 21a: ¹H NMR (300 MHz,
CDCl3): δ = 6.91 (d,
1 H, J = 2.7 Hz), 6.55 (1 H, d, J = 2.7 Hz), 5.55 (m, 1 H),
5.04 (m, 2 H), 2.34 (d, 2 H, J = 8.1
Hz), 1.27 (s, 3 H), 1.23 (s,
9 H). ¹³C
NMR (150 MHz, CDCl3): δ = 179.1, 149.1,
149.0, 145.4, 133.8, 132.5, 119.5, 45.3, 42.9, 35.3, 29.5, 25.6.
ESI-HRMS: m/z calcd for C14H20ClO [M + H]+:
239.1197; found: 239.1185.
Compound 21b: ¹H
NMR (300 MHz, CDCl3): δ = 7.18 (d,
1
H, J = 3.0 Hz), 6.56 (d, 1 H, J = 3.0 Hz), 5.53 (m, 1 H),
5.04 (m, 2 H), 2.33 (d, 2 H, J = 6.9
Hz), 1.27 (s, 3 H), 1.22 (s,
9 H). ¹³C
NMR (150 MHz, CDCl3): δ = 178.9, 153.6,
149.0, 145.1, 132.5, 126.4, 119.5, 45.1, 44.4, 35.4, 29.5, 25.5.
ESI-HRMS: m/z calcd for C14H20BrO [M + H]+:
283.0692; found: 283.0688.
Compound 21c: ¹H
NMR (300 MHz, CDCl3): δ = 7.50 (d,
1
H, J = 2.7 Hz), 6.57 (d, 1 H, J = 2.7 Hz), 5.54 (m, 1 H),
5.04 (m, 2 H), 2.32 (d, 1 H, J = 6.9
Hz), 2.29 (d, 1 H, J = 7.8 Hz), 1.27
(s, 3 H), 1.21 (s, 9 H). ¹³C NMR (150
MHz, CDCl3):
δ = 179.6, 161.9,
149.3, 143.8, 132.5, 119.5, 107.6, 46.1, 45.0, 35.5, 29.5, 25.3.
ESI-HRMS: m/z calcd for C14H20IO [M + H]+:
331.0553; found: 331.0549.
Compound 21d: ¹H
NMR (300 MHz, CDCl3): δ = 7.16 (d,
1
H, J = 2.7 Hz), 6.55 (1 H, d, J = 2.7 Hz), 5.47 (m, 1 H),
5.01 (m, 2 H), 2.40 (m, 2 H), 1.93 (hept, 1 H, J = 6.6
Hz), 0.93 (d, 3 H, J = 6.6 Hz),
0.89 (d, 3 H, J = 6.6 Hz). ¹³C
NMR (150 MHz, CDCl3): δ = 179.3, 151.8,
147.4, 147.1, 132.6, 127.6, 119.1, 51.4, 41.8; 36.2, 35.7, 29.6,
18.4, 18.2. ESI-HRMS: m/z calcd
for C16H23BrO2Na [M + Na]+:
333.0824; found: 333.0822.
Compound 21e: ¹H
NMR (300 MHz, CDCl3): δ = 7.21 (d,
1
H, J = 3.0 Hz), 6.89 (d, 1 H, J = 3.0 Hz), 5.55 (m, 1 H),
5.05 (m, 2 H), 2.33 (d, 2 H, J = 7.2
Hz), 1.27 (s, 3 H), 0.18 (s,
9 H). ¹³C
NMR (150 MHz, CDCl3): δ = 181.7, 162.9,
154.9, 139.6, 132.3, 125.4, 119.6, 46.0, 44.7, 25.0, -1.1.
ESI-HRMS: m/z calcd for C13H19BrOSiNa [M + Na]+:
321.0280; found: 321.0278.
Compound 21f: ¹H
NMR (300 MHz, CDCl3): δ = 7.16 (d,
1
H, J = 2.7 Hz), 6.84 (d, 1 H, J = 2.7 Hz), 5.53 (m, 1 H),
5.03 (m, 2 H), 2.35 (d, 2 H, J = 7.2
Hz), 1.65 (t, 2 H, J = 9.0 Hz), 1.25
(m, 2 H), 1.10 (m, 2 H), 0.85 (t, 3 H, J = 7.2
Hz), 0.19 (s, 9 H). ¹³C NMR (150 MHz,
CDCl3): δ = 182.1, 162.4, 154.3, 141.3,
132.2, 126.1, 119.4, 50.4, 44.1, 38.9, 27.2, 23.3, 14.1, -1.1.
ESI-HRMS: m/z calcd for C16H25BrOSiNa [M + Na]+:
363.0750; found: 363.0752.
Analytical Data
Compound 29a: ¹H NMR (300 MHz,
CDCl3): δ = 6.52 (s,
2 H),
2.33 (d, 2 H, J = 2.3 Hz), 2.03
(t, 1 H, J = 2.3 Hz), 1.28 (s,
3 H), 1.23 (s, 9 H). ¹³C NMR (150 MHz,
CDCl3): δ = 186.1, 146.6, 144.7, 79.8,
71.2, 38.5, 34.6, 30.9, 29.4, 25.3. ESI-HRMS: m/z calcd
for C18H27O [M + H]+:
259.2056; found: 259.2042.
Compound 29h: ¹H
NMR (300 MHz, CDCl3): δ = 6.44 (s,
2
H), 2.34 (d, 2 H, J = 2.3 Hz),
2.00 (t, 1 H, J = 2.3 Hz), 1,68 (t,
2 H, J = 8.2 Hz), 1.23 (s + q,
20 H, J = 8.2 Hz), 1.00 (sext, 2
H, J = 8.2 Hz), 0.84 (t, 3 H, J = 8.2 Hz). ¹³C
NMR (150 MHz, CDCl3): δ = 186.5, 148.1,
143.8, 79.7, 71.1, 42.3, 38.3, 34.8, 30.2, 29.4, 26.5, 22.9, 13.8.
ESI-HRMS: m/z calcd for C21H33O [M + H]+:
301.2526; found: 301.2533.
Compound 29i: ¹H
NMR (300 MHz, CDCl3): δ = 6.44 (s,
2
H), 5,73 (m, 1 H), 4.96 (d, 1 H, J = 18.7
Hz), 4,93 (d, 1 H, J = 10.5
Hz), 2.37 (d, 2 H, J =2.3 Hz),
2.03 (t, 1 H, J = 2.3 Hz), 1.81
(t, 2 H, J = 8.2 Hz), 1.43 (t,
2 H, J = 8.2 Hz), 1.24 (s, 18
H). ¹³C NMR (150 MHz, CDCl3): δ = 186.4,
148.5, 143.3, 127.6, 114.8, 79.5, 71.4, 42.2, 37.7, 34.9, 30.4,
29.4, 28.8. ESI-HRMS: m/z calcd
for C21H31O [M + H]+: 299.2369;
found: 299.2376.